Log in
Enquire now
Taiga Biotechnologies

Taiga Biotechnologies

Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer.

OverviewStructured DataIssuesContributors

Contents

taigabiotech.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Stem-cell therapy
Stem-cell therapy
Stem cell
Stem cell
Immunotherapy
Immunotherapy
Cancer immunotherapy
Cancer immunotherapy
Healthcare
Healthcare
Biomedical engineering
Biomedical engineering
Technology
Technology
...
Location
Aurora, Colorado
Aurora, Colorado
United States
United States
AngelList URL
angel.co/taiga-biotechnologies
Date Incorporated
2006
Phone Number
DUNS Number
783743938
Founded Date
2006
Total Funding Amount (USD)
40,000,000
Latest Funding Round Date
August 2020
Patents Assigned (Count)
19
Wellfound ID
taiga-biotechnologies
Country
United States
United States

Other attributes

Company Operating Status
Active
Wikidata ID
Q30283895

Taiga Biotechnologies is a biotechnology company developing blood stem cell therapies for treating infectious diseases and cancer that is headquartered in Aurora, Colorado and was founded in 2006 by Yosef Refaili and Brian Turner.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date

Taiga Biotechnologies Awarded Orphan Drug Designation for Stem Cell Therapy

Business Wire

https://www.businesswire.com/news/home/20160613006541/en/Taiga-Biotechnologies-Awarded-Orphan-Drug-Designation-Stem

Web

References

Find more companies like Taiga Biotechnologies

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.